← all drugs
Cefotaxime Sodium Powder, for Solution
in shortage · Anti-Infective · Snapshot: 2026-08-25
Day 4,207
of this shortage, counting from the FDA's first posting on 02/17/2015
- Manufacturers listed
- Hikma Pharmaceuticals USA, Inc., SteriMax, Inc.
- Reported reason(s)
- Demand increase for the drug
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02) | SteriMax, Inc. | Available | 06/15/2026 |
| Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 08/13/2026 |
| Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02) | SteriMax, Inc. | Available | 06/15/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.